TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

FaR-RMS Trial - Clinical trial database

Database services
For medical use
West Midlands (UKG)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UNIVERSITY OF BIRMINGHAM: "FaR-RMS Trial - Clinical trial database". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUNIVERSITY OF BIRMINGHAMScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: UNIVERSITY OF BIRMINGHAM
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for UNIVERSITY OF BIRMINGHAM. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUNIVERSITY OF BIRMINGHAM
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published7 Oct 2021, 11:57 BST
Last source update7 Oct 2021, 11:57 BST
Recurring procurementNot published
ClassificationDatabase services, For medical use
Delivery area
West Midlands (UKG)
OCIDocds-h6vhtk-02e92d
What is being bought
The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required.
What changed
From the official release history
  1. Status changed to complete
    7 Oct 2021, 11:57 BST
  2. Official notice release published
    7 Oct 2021, 11:57 BST
  3. Buyer information updated
    7 Oct 2021, 11:57 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required. The preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    7 Oct 2021, 11:57 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 4 Oct 2021, 00:00 BST · £500,000
Commercial outcome and competition
Awards
Viedoc Technologies AB
Not published · Not published · active
Contracts
Contract
£500,000 · signed 4 Oct 2021, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

UNIVERSITY OF BIRMINGHAM

Contracting authority GB-FTS-534
View buyer profile

  • UNIVERSITY OF BIRMINGHAM
    buyer

    Edgbaston, BIRMINGHAM, UKG31, B152TT
    p.markham@bham.ac.uk

  • The University of Birmingham
    reviewBody

    Edgbaston, Birmingham, B15 2TT

  • Viedoc Technologies AB
    supplier

    S:t Persgatan 6, Uppsala, SE, 75320
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial. The following are detailed reasons for the selection of Viedoc TM as a vendor to provide a clinical trial database for FaR-RMS: • Able to perform a 'rescue' mission and align an existing clinical database that is in use into a single database for the study • Able to deliver a live clinical trial database for the study in 2021 • Qualified by the University of Birmingham as a regulatory compliant clinical trial database • Fall under a maximum budget of £500,000 for the whole clinical trial database